Moderna CapEx increased by 59.0% to $62.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 47.0%, from $117.00M to $62.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -9.3% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.00M | $99.00M | $120.00M | $132.00M | $87.00M | $89.00M | $92.00M | $113.00M | $234.00M | $140.00M | $220.00M | $196.00M | $182.00M | $151.00M | $522.00M | $117.00M | $3.00M | $33.00M | $39.00M | $62.00M |
| QoQ Change | — | +230.0% | +21.2% | +10.0% | -34.1% | +2.3% | +3.4% | +22.8% | +107.1% | -40.2% | +57.1% | -10.9% | -7.1% | -17.0% | +245.7% | -77.6% | -97.4% | >999% | +18.2% | +59.0% |
| YoY Change | — | — | — | — | +190.0% | -10.1% | -23.3% | -14.4% | +169.0% | +57.3% | +139.1% | +73.5% | -22.2% | +7.9% | +137.3% | -40.3% | -98.4% | -78.1% | -92.5% | -47.0% |